Laura qualified as pharmacist and obtained a master in pharmacovigilance before joining the European Medicines Agency (EMA) where she covered several roles. Laura worked in the compliance department at EMA dealing with GCP and pharmacovigilance inspections, as well as in the team responsible for the implementation of the new European regulation on clinical trials and the development on the IT platform, CTIS. Laura has led the revision of the transparency rules for CTIS and since October 2023 has been appointed as Programme Manager for the ACT EU initiative.